TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Humanigen, Inc. (NASDAQ: HGEN) Investor Securities Class Action Lawsuit 08/26/2022

  • If you purchased a significant amount of shares of Humanigen, Inc. (NASDAQ: HGEN) between May 28, 2021 and July 12, 2022, and / or if you purchased any NASDAQ: HGEN shares prior to May 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: October 25, 2022. NASDAQ: HGEN investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

August 26, 2022 - An investor in shares of Humanigen, Inc. (NASDAQ: HGEN) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Humanigen, Inc. in connection with certain allegedly false and misleading statements made between May 28, 2021 and July 12, 2022. Burlingame, CA based Humanigen, Inc., a clinical stage ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)